Targeted
Acid Suppression
Rabeprazole and domperidone benefit gastrointestinal health. Rabeprazole has faster anti-secretory activity onset and greater pH inhibition than omeprazole. It reduces nocturnal acid breakthrough duration and increases intragastric pH. Domperidone improves GI motility and offers consistent acid suppression, even at night.
Designed to
Stop Reflux
Rabeprazole and domperidone improve GI health by reducing acid production and enhancing motility. Rabeprazole has a faster onset and greater pH inhibition than omeprazole, while also reducing nocturnal acid breakthrough. Meanwhile, domperidone offers consistent acid suppression, even at night, and improves GI motility.
Rabeprazole
- Faster onset of anti-secretory activity than omeprazole 20 mg (1)
- Greater degree of inhibition of pH suppression after the Ist dose (2)
- Reduces the duration of NAB & increases intragastric pH to above
- 4-6 after sleeping
Domperidone
- Improves GI motility
- More effective than cisapride (3)
- Offers consistent acid suppression even during night time
1. Aliment Pharmacol Ther. 1998 Nov;12(11):1079-89 | 2. Ail. Pharamcol Ther 2003; 17: 1109-1114 | 3. Ail. Pharamcol Ther 2002 May; 16(5): 951-7
Tempting Foods ...
When leads to Reflux
- Reduces nocturnal acid breakthrough
- Consistent acid suppression even at night
- Faster onset & greater pH inhibition
